Concurrent primaries of vaginal clear cell adenocarcinoma and endometrial adenocarcinoma in a 39-year old woman with in utero diethylstilbestrol exposure

International Journal of Gynecological Cancer

Volumn 11, Issue 3, 2001, Pages 247-250

  Keller, C ^a   Nanda, R ^a   Shannon, R L ^a   Amit, Amnon ^a,b   Kaplan, A L ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Clear cell cancer of the vagina; Diethylstilbestrol; Endometrial neoplasms

Indexed keywords

DIETHYLSTILBESTROL;

ADULT; ARTICLE; CASE REPORT; CLEAR CELL CARCINOMA; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; VAGINA CARCINOMA;

ADENOCARCINOMA; ADENOCARCINOMA, CLEAR CELL; ADULT; CARCINOGENS; DIAGNOSIS, DIFFERENTIAL; DIETHYLSTILBESTROL; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; NEOPLASMS, MULTIPLE PRIMARY; VAGINAL NEOPLASMS;

EID: 0034938918     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.2001.01007.x     Document Type: Article

References (7)

1. Behavior of estrogen-associated female genital tract cancer and its relation to neoplasm following intrauterine exposure to diethylstilbestrol (DES)
2. Cancer risk in women exposed to diethylstilbestrol in utero
3. Endometrial adenocarcinoma after in utero diethylstilbestrol exposure
4. Transplacental administration of diethylstilbestrol causes lesions in female reproductive organs of Donryn rats, including endometrial neoplasia
5. Tamoxifen induced endometrial and vaginal cancer in rats in the absence of endometrial hyperplasia
6. Uterine carcinoma in mice treated neonatally with tamoxifen
7. Coincidence of vaginal clear cell adenocarcinoma and endometrial adenocarcinoma